Electronic Health Record-Enabled Evidence-Based Smoking Cessation Quality Improvement Implementation Program

NCT04107857 | Completed

• 2 other identifiers: 89276P30CA091842
• Study Type: observational
• Target: 1,000,000
• Locations: 1 country
• Sites: 1

Brief Summary

The goal of this quality improvement program is to implement, evaluate, and sustain an evidence-based smoking cessation treatment program with a population-based approach so that all patients at the Siteman Cancer Center, Washington University, Barnes-Jewish Hospital, BJC Healthcare, and satellite locations receive assessment of smoking and all smokers receive treatment support.

Conditions

Smoking Cessation

Outcome Measures

Primary Outcomes (3)

• Clinic level percentage of patients receiving brief counseling

  From 6 months pre-intervention through 6 months post-intervention

• Clinic level percentage of smokers offered referral to additional counseling

  From 6 months pre-intervention through 6 months post-intervention

• Clinic level percentage of smokers offered medication

  From 6 months pre-intervention through 6 months post-intervention

Secondary Outcomes (6)

• Clinic level percentage of patients receiving brief counseling

  Estimated to be 12 months pre-intervention and 12, 24, 36, and 48 months post-intervention

• Clinic level percentage of smokers offered referral to additional counseling

  Estimated to be 12 months pre-intervention and 12, 24, 36, and 48 months post-intervention

• Clinic level percentage of smokers offered medication

  Estimated to be 12 months pre-intervention and 12, 24, 36, and 48 months post-intervention

• Clinic level percentage of smokers receiving smoking assessment

  Estimated to be 12 months pre-intervention and 12, 24, 36, and 48 months post-intervention

• Clinic level percentage of smokers receiving cessation medication

  Estimated to be 12 months pre-intervention and 12, 24, 36, and 48 months post-intervention

Study Arms (1)

Smoking Cessation

* Patients enter the program through clinic appointments or community outreach programs. * Patients will be given brief advice to quit smoking and referral options to receive evidence-based treatment through Missouri/Illinois Quitlines, Smokefree.TXT, or smokefree.gov dependent on the patient's preference for counseling * Patient can also be prescribed smoking cessation pharmacotherapy

Behavioral: ELEVATE enhancement to electronic health record (EHR) to improve cessation counseling offer; Behavioral: ELEVATE enhancement to electronic health record (EHR) to improve smoking cessation medication offer; Behavioral: Data Driven Feedback reports

Interventions

ELEVATE enhancement to electronic health record (EHR) to improve cessation counseling offer BEHAVIORAL

* Brief advise to quit smoking * Referral to Missouri/Illinois Quitlines, Smokefree.TXT, or smokefree.gov

Smoking Cessation

ELEVATE enhancement to electronic health record (EHR) to improve smoking cessation medication offer BEHAVIORAL

-Nicotine replacement therapy, varenicline, bupropion, or combination therapy (not provided by study)

Smoking Cessation

Data Driven Feedback reports BEHAVIORAL

-Feedback reports will be based on data

Smoking Cessation

Eligibility Criteria

• Age: 18 Years+
• Sex: all
• Healthy Volunteers: Yes
• Age Groups: Adult (18-64), Older Adult (65+)
• Sampling Method: Non-Probability Sample

Study Population

Patients 18 years of age or older

You may qualify if:

• Patients seen at Siteman Cancer Center, Washington University, Barnes-Jewish Hospital, BJC Healthcare, or any of the satellite locations

You may not qualify if:

• None

Sponsors & Collaborators

• Washington University School of Medicine: lead
• National Cancer Institute (NCI): collaborator
• National Institutes of Health (NIH): collaborator

Study Sites (1)

Washington University School of Medicine

St Louis, Missouri, 63110, United States

Location

Related Links

• Alvin J. Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine
• Related Info

MeSH Terms

Conditions

Smoking Cessation

Condition Hierarchy (Ancestors)

Health Behavior; Behavior

Study Officials

• Li-Shiun Chen, M.D., ScD, MPH

  Washington University School of Medicine

  PRINCIPAL INVESTIGATOR

Study Design

• Study Type: observational
• Observational Model: ECOLOGIC OR COMMUNITY
• Time Perspective: OTHER
• Sponsor Type: OTHER
• Responsible Party: SPONSOR

Study Record Dates

• First Submitted: September 25, 2019
• First Posted: September 27, 2019
• Study Start: October 2, 2019
• Primary Completion: April 2, 2020
• Study Completion: October 2, 2024
• Last Updated: December 20, 2024

Record last verified: 2024-12

Data Sharing

• IPD Sharing: Will not share

Locations

US (1)